Zagreb, Croatia

Zdenko Mubrin

This inventor holds 1 USPTO granted patent. Top assignee: Pliva Farmaceutska. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zdenko Mubrin. Retrieved from https://idiyas.com/inventor/zdenko-mubrin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zdenko Mubrin: Innovator in Pharmaceutical Chemistry

Introduction

Zdenko Mubrin is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on peptidoglycan derivatives. His research focuses on developing compounds that have potential applications in immunology.

Latest Patents

Zdenko Mubrin holds a patent for N-acyl derivatives of the peptidoglycan monomer. This patent describes a process for the preparation of these derivatives, which are indicated for use as immunomodulators and immunoadjuvants in both humans and animals. The formula includes various acyl groups derived from straight-chain, branched-chain, unsaturated, and aromatic carboxylic acids, along with their pharmaceutically acceptable salts.

Career Highlights

Zdenko Mubrin is associated with Pliva Farmaceutska, a prominent pharmaceutical company. His work at Pliva has allowed him to contribute to the development of innovative pharmaceutical products. His expertise in the field has positioned him as a valuable asset to the company and the industry.

Collaborations

Zdenko has collaborated with several professionals in his field, including Radmila Naumski and Vera Gomercic. These collaborations have enhanced his research and contributed to the advancement of pharmaceutical sciences.

Conclusion

Zdenko Mubrin's contributions to pharmaceutical chemistry, particularly through his patent on N-acyl derivatives of the peptidoglycan monomer, highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…